Company intelligence / Profile preview

DiaSorin Inc.

Saluggia, Italy

Ownership: Private
Employees: ~1648
Development stage: Other

Overview

DiaSorin S.p.A. is a global leader in in vitro diagnostics, specializing in immunodiagnostics and molecular diagnostics with a broad menu of CLIA assays, developing and commercializing diagnostic solutions primarily through its LIAISON® platform family.

Industry: Molecular Diagnostics

Partnerships

Roche (strategic agreement for LIAISON® XL connectivity to cobas 8100 platform)Qiagen (tuberculosis testing partnership)Quest Laboratories (Vitamin D agreement)Beckman Coulter (Hepatitis and HIV commercialization in China)Laboratory Corporation (extended agreement)TTP (Point-of-Care molecular solution development)BARDA (clinical validation support)

Beyond the preview

Go deeper on DiaSorin Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiaSorin Inc..

Explore the full profile